Update on the Clinical Trial for Alveolar Soft Part Sarcoma at the Dana Farber Cancer Institute in Boston
October 11, 2006 The clinical trial “GVAX Cancer Vaccine” started in January 2006 and enrollment is still open to new patients. So far 11 patients were selected to participate in the trial. Eight of those patients have the diagnosis of Alveolar Soft Part Sarcoma (ASPS). All the eight ASPS patients have completed the study. There […]